[1]Li YJ,Huang GL,Sun XL,et al.The combination therapy of high-intensity focused ultrasound with radiotherapy in locally advanced pancreatic carcinoma[J].World J Surg Oncol,2016,14(1):1-5.
[2]Khokhlova TD,Hwang JH.HIFU for palliative treatment of pancreatic cancer[J].Adv Exp Med Biol,2016,880(3):83-95.
[3]Rombouts SJE,Vogel JA,Santvoort HC,et al.Systematic review of innovative ablative therapies for the treatment of locally advanced pancreatic cancer[J].Br J Surg,2015,102(3):182-193.
[4]Zhou Y.High-intensity focused ultrasound treatment for advanced pancreatic cancer[J].Gastroenterol Res Pract,2014,2014(1):205325.
[5]Hijnen N,Langereis S,Grüll H.Magnetic resonance guided high-intensity focused ultrasound for image-guided temperature-induced drug delivery[J].Adv Drug Deliv Rev,2014,72(6):65-81.
[6]Lam MK,Huisman M,Nijenhuis RJ,et al.Quality of MR thermometry during palliative MR-guided high-intensity focused ultrasound(MR-HIFU)treatment of bone metastases[J].J Ther Ultrasound,2015,3(1):1-15.
[7]Wolfram F,Reichenbach JR,Lesser TG.An exvivo,human lung model for ultrasound-guided high-intensity focused ultrasound therapy using lung flooding[J].Ultrasound Med Biol,2014,40(3):496-503.
[8]Patel K,Kollory A,Takashima A,et al.MicroRNA let-7 downregulates STAT3 phosphorylation in pancreatic cancer cells by increasing SOCS3 expression[J].Cancer Lett,2014,347(1):54-64.
[9]Cowan RW,Maitra A,Rhim AD.A new scalpel for the treatment of pancreatic cancer:Targeting stromal-derived STAT3 signaling[J].Gastroenterology,2015,149(7):1685-1688.
[10]Sofuni A,Itoi T,Sano T,et al.Sa1466 usefulness of high-intensity focused ultrasound(HIFU)Tterapy for unresectable pancreatic cancer[J].World J Gastroenterol,2014,20(28):9570-9577.
[11]Fofaria NM,Srivastava SK.STAT3 induces anoikis resistance,promotes cell invasion and metastatic potential in pancreatic cancer cells[J].Carcinogenesis,2015,36(1):142-150.
[12]Niu F,Li Y,Lai FF,et al.LB-1 exerts antitumor activity in pancreatic cancer by inhibiting HIF-1α and Stat3 signaling[J].J Cell Physiol,2015,230(9):2212-2223.